D

Dyne Therapeutics

123 employees

Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Medical
Pharmaceutical

Date founded

2018

Funding rounds raised

Total raised

$115M

from 11 investors over 11 rounds

D

Dyne Therapeutics raised $115M on August 10, 2020

Investors: Atlas Venture, Vida Ventures, LLC, Forbion, MPM Capital, Surveyor Capital, Logos Global Management, LP and Wellington Management

D

Dyne Therapeutics raised $50M on April 3, 2019

Investors: Atlas Venture, Forbion and MPM Capital

D

Dyne Therapeutics raised undisclosed on January 1, 2018

Investors: RA Capital Management, L.P.

FAQ